Biomarkers Predicting Recurrence and Progression of Ductal Carcinoma In Situ Treated by Lumpectomy Alone

被引：8
|
作者：
Allred, D. Craig [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2010年 / 102卷 / 09期
关键词：
SURGICAL ADJUVANT BREAST; INTRADUCTAL-CARCINOMA; PATHOLOGICAL FINDINGS; PROTOCOL B-17; CANCER; TAMOXIFEN; EXPRESSION; PHENOTYPE; DCIS; B-24;
D O I：
10.1093/jnci/djq118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：585 / 587
页数：3
相关论文
共 50 条
  • [21] Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis
    Zhang, Xining
    Dai, Hongji
    Liu, Ben
    Song, Fengju
    Chen, Kexin
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2016, 25 (01) : 19 - 28
  • [22] Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ
    Davis, James E.
    Nemesure, Barbara
    Mehmood, Saira
    Nayi, Vipul
    Burke, Stephanie
    Brzostek, Sabrina R.
    Singh, Meenakshi
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (01) : 20 - 25
  • [23] The locoregional recurrence post-mastectomy for ductal carcinoma in situ: Incidence and risk factors
    Bannani, Sahar
    Rouquette, Sophie
    Bendavid-Athias, Cecile
    Tas, Patrick
    Leveque, Jean
    BREAST, 2015, 24 (05): : 608 - 612
  • [24] A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
    Solin, Lawrence J.
    Gray, Robert
    Baehner, Frederick L.
    Butler, Steven M.
    Hughes, Lorie L.
    Yoshizawa, Carl
    Cherbavaz, Diana B.
    Shak, Steven
    Page, David L.
    Sledge, George W., Jr.
    Davidson, Nancy E.
    Ingle, James N.
    Perez, Edith A.
    Wood, William C.
    Sparano, Joseph A.
    Badve, Sunil
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (10): : 701 - 710
  • [25] Ductal Carcinoma In Situ and Progression to Invasive Cancer: A Review of the Evidence
    Heller, Samantha L.
    Plaunova, Anastasia
    Gao, Yiming
    JOURNAL OF BREAST IMAGING, 2021, 3 (02) : 135 - 143
  • [26] Myoepithelial Cell Differentiation Markers in Ductal Carcinoma in Situ Progression
    Russell, Tanya D.
    Jindal, Sonali
    Agunbiade, Samiat
    Gao, Dexiang
    Troxell, Megan
    Borges, Virginia F.
    Schedin, Pepper
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (11): : 3076 - 3089
  • [27] Ductal Carcinoma in Situ: Molecular Changes Accompanying Disease Progression
    Wilson, Gemma M.
    Dinh, Phuong
    Pathmanathan, Nirmala
    Graham, J. Dinny
    JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2022, 27 (01) : 101 - 131
  • [28] Factors Predicting Microinvasion in Ductal Carcinoma in situ
    Ozkan-Gurdal, Sibel
    Cabioglu, Neslihan
    Ozcinar, Beyza
    Muslumanoglu, Mahmut
    Ozmen, Vahit
    Kecer, Mustafa
    Yavuz, Ekrem
    Igci, Abdullah
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (01) : 55 - 60
  • [29] Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma
    Rebbeck, Clare A.
    Xian, Jian
    Bornelov, Susanne
    Geradts, Joseph
    Hobeika, Amy
    Geiger, Heather
    Alvarez, Jose Franco
    Rozhkova, Elena
    Nicholls, Ashley
    Robine, Nicolas
    Lyerly, Herbert K.
    Hannon, Gregory J.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [30] Cytologic evaluation of lumpectomy margins in patients with ductal carcinoma in situ: Clinical outcome
    Charles E. Cox
    Micheline Hyacinthe
    Ricardo J. Gonzalez
    Gary Lyman
    Douglas Reintgen
    Ni Ni Ku
    Marcia S. Miller
    Harvey Greenberg
    Santo V. Nicosia
    Annals of Surgical Oncology, 1997, 4 : 644 - 649
12345